Can Immunotherapy Offer Hope for Parkinson’s Sufferers?
Despite decades of research, effective treatments for Parkinson’s disease are proving elusive. Could immunotherapy finally…
Despite decades of research, effective treatments for Parkinson’s disease are proving elusive. Could immunotherapy finally…
The prevalence of neurological diseases has increased rapidly, and they are now the second biggest…
A new platform makes automated western blot processing accessible to more labs, freeing up researchers’…
Effective therapies for neurodegenerative diseases like Alzheimer's are urgently needed. But developing new drugs is…
AC Immune and Genentech’s drug has failed to slow the progression of Alzheimer’s disease in…
An international group of researchers has set up a brain-machine interface between cultured nerve cells…
A project has launched with a €3.6M grant to treat neurological conditions such as Alzheimer’s…
With big pharma exiting the neurology space in droves, biotech innovation might be the key…
Modag has developed a candidate drug targeting the neurodegenerative disease multiple system atrophy, which it…
The Swiss city of Lausanne is perhaps best known as a hub of international sport,…
The failure of Biogen’s Alzheimer’s disease drug in a phase III trial last week caused…
Update (23/01/2019): The FDA has given uniQure regulatory clearance to begin a phase I/II trial…